Population pharmacokinetics of intramuscular gentamicin administered to young infants with suspected severe sepsis in Kenya

British Journal of Clinical Pharmacology

Volumn 56, Issue 1, 2003, Pages 25-31

  Thomson, Alison H ^a,b   Kokwaro, Gilbert O ^c   Muchohi, Simon N ^c   English, Michael ^c,d   Mohammed, Shebbe ^c   Edwards, Geoffrey ^e,f  

^a WESTERN INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

^f LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Gentamicin; Infants; Intramuscular injection; Pharmacokinetics

Indexed keywords

GENTAMICIN;

ANTIBIOTIC THERAPY; ARTICLE; BODY WEIGHT; COMPARTMENT MODEL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN SEPSIS; POPULATION RESEARCH; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BIOLOGICAL AVAILABILITY; GENTAMICINS; HUMANS; INFANT; INFANT, NEWBORN; INJECTIONS, INTRAMUSCULAR; SEPSIS;

EID: 0037998663     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2003.01819.x     Document Type: Article

References (12)

1. Chuck SK, Raber SR, Rodvold KA, Areff D. National survey of extended-interval aminoglycoside dosing. Clin Inf Dis 2000; 30: 433-439.
2. Condren M, Luedtke SA. Prescribing patterns for extended interval aminoglycoside dosing in pediatric patients. J Pediatr Pharmacol Ther 2001; 6: 385-391.
3. De Hoog M, Mouton J, van den Anker JN. The use of aminoglycosides in newborns. Paed Perinatal Drug Ther 1998; 2: 48-56.
4. English M, Mohammed S, Ross A et al. A randomized, pragmatic, comparative trial in young Kenyan infants of once daily and multi-dose daily gentamicin. Br Med J.
5. Beal SL, Sheiner LB, Boeckmann AJ. NONMEM IV user's guide, Parts I-VI. San Francisco: NONMEM Project Group, University of California, 1994.
6. Jonsson N, Kadsson MO. Xpose - an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comp Meth Prog Biomed 1999; 58: 51-64.
7. Paisley JW, Smith AL. Gentamicin in newborn infants. Comparison of intramuscular and intravenous administration. Am J Dis Child 1973; 126: 51-64.
8. Hayani KC, Hatzopoulos FK, Frank AL et al. Pharmacokinetics of once-daily dosing in neonates. J Pediatr 1997; 131: 76-80.
9. Jensen PD, Edgren B, Brundage RC. Population pharmacokinetics of gentamicin in neonates using a nonlinear, mixed effects model. Pharmacotherapy 1992; 12: 178-182.
10. Weber W, Kewitz KL, Looby M, Nitz M, Harnisch L. Population kinetics of gentamicin in neonates. Eur J Clin Pharmacol 1993; 44: s23-s25.
11. Anderson B, McKee AD, Holford NHG. Size, myths and the clinical pharmacokinetics of analgesics in pediatric patients. Clin Pharmacokinet 1997; 33: 313-327.
12. Besunder JB, Reed MD, Blumer JL. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I). Clin Pharmacokinet 1988; 14: 189-216.